You are viewing: South Korea Custom Antibody Market analysis
Part of: Custom Antibody Market (Global)

The South Korea Custom Antibody Market was valued at $4.4 Million in 2024 and projected to reach to $6.7 Million by 2029, representing a compound annual growth rate of 8.9%. South Korea's custom antibody market is poised for sustained expansion through 2029, driven by the nation's advanced biotechnology infrastructure and increasing pharmaceutical R&D investments.

South Korea Custom Antibody Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Custom Antibody Market Trends and Insights

  • This expansion reflects South Korea's strengthening position in the Asia Pacific region's biotechnology and pharmaceutical sectors.
  • South Korea's investment in research and development, coupled with increasing demand for personalized therapeutics, is driving adoption of custom antibody solutions across academic institutions and biopharmaceutical companies. The 8.9% compound annual growth rate (CAGR) through 2029 underscores South Korea's commitment to advancing immunotherapy and diagnostic capabilities.
  • South Korea's robust healthcare infrastructure and government support for life sciences innovation are key enablers of market growth.
  • South Korea continues to attract both domestic and international players seeking to develop tailored antibody therapeutics for oncology, autoimmune, and infectious disease applications..

Key Market Statistics

  • CAGR (2024-2029) 8.9% CAGR
  • Market Size, 2024 ~USD 4.4 Million
  • Forecast, 2029 ~USD 6.7 Million
  • Country South Korea

South Korea Custom Antibody Market Overview

Market Valuation Growth :

South Korea's custom antibody market is valued at $4.4 million in 2024, with projections reaching $6.7 million by 2029, representing a robust 8.9% CAGR over the forecast period.

R&D Investment Leadership :

South Korea's commitment to biotechnology research and development is driving custom antibody adoption, with government initiatives and private sector investments strengthening the market foundation.

Personalized Medicine Demand :

Increasing demand for personalized therapeutics in South Korea is accelerating custom antibody development, as pharmaceutical companies seek tailored solutions for targeted disease treatment.

Asia Pacific Positioning :

South Korea is establishing itself as a key player in the Asia Pacific biotechnology sector, leveraging advanced manufacturing capabilities and skilled scientific workforce for custom antibody production.

South Korea Custom Antibody Market Dynamics

  • The market benefits from South Korea's strong healthcare system, government support for life sciences innovation, and growing collaboration between academic institutions and industry players.
  • Personalized medicine initiatives and the rising prevalence of chronic diseases are expected to fuel demand for custom antibodies in therapeutic development.
  • South Korea's strategic position in the Asia Pacific region, combined with its manufacturing excellence and skilled workforce, positions the country as an emerging hub for custom antibody development and commercialization..

Market Ecosystem

logo-mobile

CUSTOM ANTIBODY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Provides custom antibody development and production services, including monoclonal, polyclonal, and recombinant antibody generation. Its services cover antigen design, antibody screening, purification, and characterization for research and diagnostic applications. Supports the development of application-specific antibodies with defined target specificity and performance, helping pharmaceutical companies, biotechnology firms, and academic researchers accelerate target validation and assay development.
company logo
Offers custom antibody production and engineering services through its antibody development capabilities, including GeneArt high-throughput antibody expression, gene synthesis, cloning, transient expression, purification, and quality control. Enables researchers to obtain custom antibodies for research and development workflows, supporting faster antibody production, consistent quality, and applications in biologics development, protein analysis, and diagnostic research.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • South Korea's custom antibody market is valued at $4.4 million in 2024 and is expected to reach $6.7 million by 2029, representing an 8.9% CAGR.
    • South Korea's strong R&D ecosystem and government backing are accelerating adoption of custom antibody technologies in therapeutic development.
    • South Korea's biopharmaceutical sector is increasingly leveraging custom antibodies for precision medicine and immunotherapy applications.
    • South Korea's market growth is supported by rising collaborations between academic institutions and commercial entities in the life sciences space.

    Custom Antibody Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment ONCOLOGY (Indication)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.2% from 2024 to 2029
    Largest Segment RESEARCH (Application)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.9 (2029)
    Segments Covered Service, Type, Source, Application, Indication, End User

    South Korea Custom Antibody Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Service

    • Antibody Development
    • Antibody Fragmentation & Labeling
    • Antibody Fragmentation & Labelling
    • Antibody Production & Purification

    By Type

    • Antibody Characterization
    • Antigen Preparation
    • Immunization & Hybridoma Production
    • Monoclonal Antibodies
    • Other Antibodies
    • Other Custom Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibodies

    By Source

    • Mice
    • Other Sources
    • Rabbits

    By Application

    • Research
    • Therapeutic

    By Indication

    • Cardiovascular Diseases
    • Immunology
    • Infectious Diseases
    • Neurobiology
    • Oncology
    • Other Indications

    By End User

    • Academic & Research Institutes
    • Contract Research Organizations
    • Cros
    • Pharmaceutical & Biotechnology Companies

    Target Audience

    • Pharmaceutical Companies : South Korean and international pharma firms need market data to identify custom antibody sourcing opportunities, assess local manufacturing partnerships, and develop targeted therapeutic solutions for Korean patients.
    • Biotechnology Startups : Emerging biotech companies in South Korea require market insights to validate business models, secure funding, and position custom antibody offerings within the competitive Korean and Asia Pacific landscape.
    • Contract Research Organizations (CROs) : CROs operating in South Korea need market intelligence to expand custom antibody service portfolios, identify client demand patterns, and optimize resource allocation for Korean pharmaceutical clients.
    • Investment & Venture Capital Firms : Investors targeting South Korea's life sciences sector require market data to evaluate funding opportunities, assess growth potential of custom antibody companies, and make informed portfolio decisions.
    • Government & Regulatory Bodies : South Korean health authorities and policy makers need market analysis to inform biotech development strategies, allocate R&D incentives, and establish regulatory frameworks supporting custom antibody innovation.

    Reasons to Buy this Report

    • Market-Specific Sizing Data : Access precise valuation figures for South Korea's custom antibody market with verified 2024 baseline ($4.4M) and 2029 forecasts ($6.7M), enabling accurate budget allocation and investment planning.
    • Regional Growth Trajectory Analysis : Understand South Korea's 8.9% CAGR performance relative to global 9.2% growth, identifying market dynamics unique to the Korean biotechnology ecosystem and competitive positioning opportunities.
    • Strategic Market Entry Intelligence : Gain insights into South Korea's R&D investment landscape, government support mechanisms, and pharmaceutical sector dynamics essential for market entry, partnership development, and expansion strategies.
    • Personalized Medicine Opportunity Assessment : Evaluate the growing demand for custom antibodies in South Korea's personalized therapeutics sector, identifying high-potential applications and customer segments for product development.
    • Competitive Landscape Benchmarking : Benchmark your organization against South Korea's emerging custom antibody players, understanding local manufacturing capabilities, regulatory environment, and collaboration opportunities with Korean biotech firms.

    Frequently asked questions

    What is the current size of South Korea's custom antibody market?

    South Korea's custom antibody market was valued at $4.4 million in 2024 and is projected to grow to $6.7 million by 2029.

    What is the expected growth rate for South Korea's custom antibody market?

    South Korea's custom antibody market is expected to grow at a compound annual growth rate (CAGR) of 8.9% from 2024 to 2029.

    What factors are driving growth in South Korea's custom antibody market?

    South Korea's market growth is driven by increased R&D investment, government support for biotechnology, rising demand for personalized therapeutics, and expanding applications in oncology and immunotherapy.

    Which sectors in South Korea are adopting custom antibodies?

    South Korea's academic institutions, biopharmaceutical companies, and contract research organizations are increasingly adopting custom antibody solutions for therapeutic and diagnostic applications.

    How does South Korea's market compare to the broader Asia Pacific region?

    South Korea represents a significant segment within the Asia Pacific custom antibody market, with its 8.9% CAGR reflecting strong regional competitiveness and innovation capacity.

    RESEARCH METHODOLOGY

    The global custom antibody market is projected to reach USD 1.13 billion by 2031, up from USD 0.72 billion in 2026, reflecting a 9.5% CAGR over the forecast period. Market estimation involved four major activities to estimate the current size of the custom antibody market. Exhaustive secondary research was conducted to gather information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the total market size. Following this, data triangulation was used to estimate the market size of segments and subsegments.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the custom antibody market. The secondary sources used for this study include Antibody Society, Antibody Therapeutics, Pharmaceutical Research and Manufacturers of America (PhRMA), National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), American Medical Association (AMA), Association of Medical Laboratory Immunologists (AMLI), Central Drugs Standard Control Organisation (CDSCO), Center for Drug Evaluation and Research (CDER), Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), World Health Organization (WHO), and United States Food & Drug Administration (USFDA).

    Secondary sources also include corporate and regulatory filings (annual reports, SEC filings, investor presentations, and financial statements); business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess market prospects. Primary sources from both the supply and demand sides of the market were interviewed to gather qualitative and quantitative data. The following is a breakdown of the primary respondents:

    Breakup of Primary Profiles:

    Custom Antibody Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The global size of the custom antibody market was estimated using multiple approaches. A detailed market estimation approach was used to estimate and validate the market value and other dependent submarkets. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following.

    Custom Antibody Market: Top-Down and Bottom-Up Approach

    Custom Antibody Market Top Down and Bottom Up Approach

    Data Triangulation

    After estimating the market size using the process described above, the total market was divided into several segments and subsegments. To finish the overall market analysis and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown methods were used where applicable. The data were triangulated by examining various factors and trends from both the demand and supply sides.

    Market Definition

    Custom antibody services include the production of antibodies from a wide variety of host species, depending on the desired outcome of the research study. These services range from antigen preparation, immunization, hybridoma production, and antibody characterization to production, purification, and labeling. The report includes the market size and forecast for custom antibody development, production, purification, and labeling services.

    Key Stakeholders

    • Academic & Research Institutes
    • Custom Antibody Service Vendors
    • Contract Research Organizations (CROs)
    • Medical Device Companies
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Private Research Firms

    Report Objectives

    • To define, describe, and forecast the custom antibody market based on service, type, source, application, indication, end user, and region
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall custom antibody market
    • To analyze opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, South Korea, India, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East (GCC Countries), and Africa
    • To profile the key players and analyze their market share and core competencies
    • To analyze competitive developments, such as service launches, partnerships, agreements, collaborations, and expansions
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

    Available customizations:

    With the provided market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following options are available for the report:

    Geographical Analysis

    • A further breakdown of the Rest of Asia Pacific custom antibody market into countries
    • A further breakdown of the Rest of Europe custom antibody market into countries
    • A further breakdown of the Rest of Latin America custom antibody market into countries

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).

    Segment Analysis

    • Cross-segment analysis.

     

    Get the Full Custom Antibody Market Report

    Full forecast, segment splits, and company analysis for all Custom Antibody Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status